A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That As a Novel Biomarker in Kidney Renal Clear Cell Carcinoma

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Aug 12

PMID 35955933

Authors

Yange Wang

Chenyang Li

Xinlei Qi

Yafei Yao

Lu Zhang

Guosen Zhang

Longxiang Xie

Qiang Wang

Wan Zhu

Xiangqian Guo

Affiliations

Soon will be listed here.

Abstract

Blood group antigen is a class of heritable antigenic substances present on the erythrocyte membrane. However, the role of blood group antigens in cancer prognosis is still largely unclear. In this study, we investigated the expression of 33 blood group antigen genes and their association with the prognosis of 30 types of cancers in 31,870 tumor tissue samples. Our results revealed that blood group antigens are abnormally expressed in a variety of cancers. The high expression of these antigen genes was mainly related to the activation of the epithelial-mesenchymal transition (EMT) pathway. High expression of seven antigen genes, i.e., , , , , , and , were significantly associated with good OS (Overall Survival) in six types of cancers, while ten genes, i.e., , , , , , , , , , and , were associated with poor OS in three types of cancers. Kidney renal clear cell carcinoma (KIRC) is associated with the largest number (14 genes) of prognostic antigen genes, i.e., , , , , , , , , , , , , , and . High expression of gene was significantly correlated with a poor prognosis of KIRC in this analysis but has not been reported previously. might be a putative biomarker for poor prognosis in KIRC. In conclusion, our analysis indicates that blood group antigens may play functional important roles in tumorigenesis, progression, and especially prognosis. These results provide data to support prognostic marker development and future clinical management.

Citing Articles

Association of Leukemia With ABO Blood Group Distribution and Discrepancy: A Review Article.

Elzein H Cureus. 2024; 16(3):e56812.

PMID: 38654809 PMC: 11036791. DOI: 10.7759/cureus.56812.

Identification of key genes and validation of key gene aquaporin 1 on Wilms' tumor metastasis.

Liu H, Jin C, Yang X, Xia N, Guo C, Dong Q PeerJ. 2023; 11:e16025.

PMID: 37904849 PMC: 10613441. DOI: 10.7717/peerj.16025.

Using Single-Cell RNA Sequencing and MicroRNA Targeting Data to Improve Colorectal Cancer Survival Prediction.

Willems A, Panchy N, Hong T Cells. 2023; 12(2).

PMID: 36672162 PMC: 9856396. DOI: 10.3390/cells12020228.

References

Okuno T, Nakatsuji Y, Kumanogoh A . The role of immune semaphorins in multiple sclerosis. FEBS Lett. 2011; 585(23):3829-35. DOI: 10.1016/j.febslet.2011.03.033. View

Hoque M, Soria J, Woo J, Lee T, Lee J, Jang S . Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth. Am J Pathol. 2006; 168(4):1345-53. PMC: 1606549. DOI: 10.2353/ajpath.2006.050596. View

Song Y, Wang L, Zhang L, Huang D . The involvement of semaphorin 7A in tumorigenic and immunoinflammatory regulation. J Cell Physiol. 2021; 236(9):6235-6248. DOI: 10.1002/jcp.30340. View

Morath I, Hartmann T, Orian-Rousseau V . CD44: More than a mere stem cell marker. Int J Biochem Cell Biol. 2016; 81(Pt A):166-173. DOI: 10.1016/j.biocel.2016.09.009. View

Zhou P, Erfani S, Liu Z, Jia C, Chen Y, Xu B . CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion. Oncotarget. 2015; 6(30):29675-93. PMC: 4745755. DOI: 10.18632/oncotarget.4896. View

Abegaz S . Human ABO Blood Groups and Their Associations with Different Diseases. Biomed Res Int. 2021; 2021:6629060. PMC: 7850852. DOI: 10.1155/2021/6629060. View

Westhoff C . Blood group genotyping. Blood. 2019; 133(17):1814-1820. DOI: 10.1182/blood-2018-11-833954. View

McFarlane S, Coulter J, Tibbits P, OGrady A, McFarlane C, Montgomery N . CD44 increases the efficiency of distant metastasis of breast cancer. Oncotarget. 2015; 6(13):11465-76. PMC: 4484469. DOI: 10.18632/oncotarget.3410. View

Wagner S, Mullins C, Linnebacher M . Colorectal cancer vaccines: Tumor-associated antigens neoantigens. World J Gastroenterol. 2019; 24(48):5418-5432. PMC: 6319136. DOI: 10.3748/wjg.v24.i48.5418. View

10.

Yun S, Sun P, Jin Y, Kim H, Park E, Park S . Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma. J Pathol Transl Med. 2016; 50(4):251-7. PMC: 4963971. DOI: 10.4132/jptm.2016.03.30. View

11.

Liang Y, He H, Han Z, Bi X, Dai Q, Ye Y . CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value. Cancer Invest. 2009; 27(7):788-93. DOI: 10.1080/07357900802709167. View

12.

Abdelrahman A, Ibrahim D, El-Azony A, Alnagar A, Ibrahim A . ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy. Cancer Biomark. 2020; 27(2):251-264. DOI: 10.3233/CBM-190994. View

13.

Denomme G . Molecular basis of blood group expression. Transfus Apher Sci. 2011; 44(1):53-63. DOI: 10.1016/j.transci.2010.12.010. View

14.

Riethdorf S, Reimers N, Assmann V, Kornfeld J, Terracciano L, Sauter G . High incidence of EMMPRIN expression in human tumors. Int J Cancer. 2006; 119(8):1800-10. DOI: 10.1002/ijc.22062. View

15.

Chen Y, Hu N, Liao L, Yu K, Shu X, Zheng W . ABO genotypes and the risk of esophageal and gastric cancers. BMC Cancer. 2021; 21(1):589. PMC: 8141232. DOI: 10.1186/s12885-021-08334-1. View

16.

Liu M, Zheng Q, Chen S, Liu J, Li S . FUT7 Promotes the Epithelial-Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma. J Inflamm Res. 2021; 14:1069-1084. PMC: 8007615. DOI: 10.2147/JIR.S296597. View

17.

Gan Y, Reilkoff R, Peng X, Russell T, Chen Q, Mathai S . Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum. 2011; 63(8):2484-94. PMC: 3651701. DOI: 10.1002/art.30386. View

18.

Chen C, Chen H, Zhang Y, Thomas H, Frank M, He Y . TBtools: An Integrative Toolkit Developed for Interactive Analyses of Big Biological Data. Mol Plant. 2020; 13(8):1194-1202. DOI: 10.1016/j.molp.2020.06.009. View

19.

Gabison E, Hoang-Xuan T, Mauviel A, Menashi S . EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 2005; 87(3-4):361-8. DOI: 10.1016/j.biochi.2004.09.023. View

20.

Otterbach F, Callies R, Kimmig R, Schmid K, Bankfalvi A . [Aquaporin 1 expression in invasive breast carcinomas]. Pathologe. 2008; 29 Suppl 2:357-62. DOI: 10.1007/s00292-008-1039-6. View